Correlations with the top 3 mutated genes (EGFR, TP53, KRAS) with patients’ demographics showed that EGFR was mainly found in female, adenocarcinomas, while TP53 was mainly found in male, non-adenocarcinomas. This evidence concerns the gene KRAS and adenocarcinoma.